MENU
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
Profile
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
137.44M
P/E Ratio
N/A
Total Cash
136.53M
Projected Growth
N/A
Total Debt
60K
Revenue
27.7M
Risk (Beta)
0.72
Dividend Yield
N/A
Total Cash/Share
2.89
Total Debt/Equity
N/A
Revenue/Share
0.59 USD as % of share price
Fundamentals
SLN
Capitalization
137M
P/E Ratio
N/A
Risk (Beta)
0.72
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
2.89
Total Debt
60K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.59%
Revenue
27.7M
ROE
N/A
Book Value
-112.74M
P/B Ratio
1.32
Cash Flow
N/A
Earnings
-1.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
-10.29M
Current Ratio
8.81
Current Revenue Per Employee
1224.14
Dividends Per Share - Security
N/A
EBITDA
-71.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
61.97
Revenue To Assets
-33.21
Shares Held By Institutions
159M
Shares Outstanding - Current
47.2M
Total Liabilities
298M
Total Volume MTD
N/A
Value
1
Gain YTD
-40.262
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com